Loading…
Curcumin analog cytotoxicity against breast cancer cells: exploitation of a redox-dependent mechanism
The glutathione conjugates of curcumin analogs represent a promising new series of stable and soluble anti-tumor pro-drugs. A series of novel curcumin analogs, symmetrical dienones, were previously shown to possess cytotoxic, anti-angiogenic and anti-tumor activities. Analogs 1 (EF24) and 2 (EF31) s...
Saved in:
Published in: | Bioorganic & medicinal chemistry letters 2009-12, Vol.19 (23), p.6627-6631 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The glutathione conjugates of curcumin analogs represent a promising new series of stable and soluble anti-tumor pro-drugs.
A series of novel curcumin analogs, symmetrical dienones, were previously shown to possess cytotoxic, anti-angiogenic and anti-tumor activities. Analogs
1 (EF24) and
2 (EF31) share the dienone scaffold and serve as Michael acceptors. We propose that the anti-cancer effects of
1 and
2 are mediated in part by redox-mediated induction of apoptosis. In order to support this concept,
1 and
2 were treated with
l-glutathione (GSH) and cysteine-containing dipeptides under mild conditions to form colorless water-soluble adducts, which were identified by LC/MS. Comparison of the cytotoxic action of
1,
2 and the corresponding conjugates,
1-(GSH)
2 and
2-(GSH)
2, illustrated that the two classes of compounds exhibit essentially identical cell killing capabilities. Compared with the yellow, somewhat light sensitive and nearly water insoluble compounds
1 and
2, the glutathione conjugates represent a promising new series of stable and soluble anti-tumor pro-drugs. |
---|---|
ISSN: | 0960-894X 1464-3405 |
DOI: | 10.1016/j.bmcl.2009.10.023 |